A Phase I clinical trial for a new investigational therapeutic antibody
Latest Information Update: 04 Jul 2024
At a glance
- Drugs Avian derived monoclonal antibody therapeutic Pharma Foods International Mitsubishi Tanabe Pharma (Primary)
- Indications Autoimmune disorders
- Focus Adverse reactions
Most Recent Events
- 04 Jul 2024 New trial record
- 28 Jun 2024 According to a Pharma Foods International Co Ltd, PFI and MTPC entered into the License Agreement in January 2021 for this investigational therapeutic antibody.
- 28 Jun 2024 According to a Pharma Foods International Co Ltd, an initial Clinical Trial Notification was submitted to Pharmaceutical and Medical Devices Agency (PMDA), and the 30-day review has been completed. Phase I clinical trial for this investigational therapeutic antibody will begin in the future.